Cassidy Koonce, MD
Surgery · Athens, ALNPI 1376854976
Payments from drug & device makers
Across 162 payments — averaging $32.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$684
- Globus Medical$591
- Bard Peripheral Vascular, Inc.$517
- Kerecis Limited$463
- Cardiovascular Systems Inc.$350
- Abbott$346
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 19 | $684 |
| Globus Medical(2 entities) | 9 | $591 |
| Bard Peripheral Vascular, Inc. | 18 | $517 |
| Kerecis Limited | 8 | $463 |
| Cardiovascular Systems Inc. | 13 | $350 |
| Abbott | 13 | $346 |
| Stryker | 2 | $308 |
| Acera Surgical, Inc. | 6 | $215 |
| Sanara Medtech Inc. | 2 | $171 |
| TELA Bio, Inc. | 11 | $161 |
| Osiris Therapeutics Inc. | 2 | $134 |
| Intuitive Surgical | 1 | $129 |
| Olympus America Inc. | 4 | $107 |
| Polynovo North America LLC | 4 | $83 |
| Aroa Biosurgery Incorporated | 3 | $80 |
| AbbVie | 4 | $76 |
| Convatec Inc. | 3 | $73 |
| Reflow Medical Inc | 3 | $67 |
| Merck | 3 | $61 |
| KCI USA, Inc. | 3 | $58 |
| Lemaitre Vascular, Inc. | 4 | $58 |
| Johnson & Johnson | 3 | $52 |
| Integra Lifesciences Corporation | 2 | $49 |
| Mimedx Group, Inc. | 2 | $47 |
| Davol Inc. | 2 | $42 |
| Cook Medical LLC | 1 | $39 |
| Bioventus LLC | 2 | $37 |
| Axonics, Inc. | 2 | $34 |
| Medtronic | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Heron Therapeutics, Inc. | 2 | $30 |
| Solventum Corporation | 1 | $27 |
| Merit Medical Systems Inc | 1 | $25 |
| Organogenesis Inc. | 1 | $24 |
| Conmed Corporation | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$662
- SPY-PHI SYSTEM$308
- ALIF$242
- Grafix$232
- Kerecis Omega3 GraftGuide$221
- Kerecis Omega3 Marigen$221
- RENASYS GO v2 HOME$133
- Da Vinci Surgical System$129
- Diamondback Peripheral$126
- Stravix$114
- GrafixPL$114
- CellerateRx$111
- Restrata Wound Matrix$100
How this compares
$5,276 in reported general payments places this provider in the 70th percentile of 382 surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 49 | $25,193 |
| Sucralfate | 154 | $4,157 |
| Omeprazole | 193 | $1,880 |
| Esomeprazole Magnesium | 63 | $1,678 |
| Famotidine | 170 | $1,262 |
| Pantoprazole Sodium | 130 | $1,173 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 192 | $706 |
| ClopidogrelClopidogrel Bisulfate | 43 | $643 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 20 | $390 |
| Dicyclomine Hcl | 44 | $387 |
| Ondansetron OdtOndansetron | 30 | $347 |
| Rabeprazole Sodium | 12 | $166 |
| Doxycycline Hyclate | 13 | $157 |
| Metronidazole | 12 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $67 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $76 | $25,19349 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 382 surgery providers in Alabama.
Other surgery in Athens
- Seth RayburnAthens$27K
- Daniel CoxBirmingham$1.2M
- John PorterfieldBessemer$972K
- Parker HuBirmingham$734K
- Barton WoodAlabaster$702K
- Forrest RingoldMobile$678K
- Adam BeckBirmingham$634K
- Jason BeaverDothan$374K
- Dennis FernandezHuntsville$266K
- Cameron AskewBirmingham$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.